디지털 치료제 시장 보고서(2026년)

Digital therapeutics (DTx) are products that deliver evidence-based therapeutic interventions to patients through high-quality software applications to prevent, manage, or treat medical conditions or diseases.

The primary product types of digital therapeutics include devices and software. Digital therapeutics devices deliver interventions designed to prevent, manage, or treat diseases and medical disorders. These include devices such as sensors that monitor medication usage and location data. The different sales channels comprise business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics are utilized for preventive applications as well as treatment and care-related applications.

Tariffs are influencing the digital therapeutics market by increasing the costs of imported wearable components, biosensors, electronic modules, and supporting hardware devices. Healthcare providers and technology companies in North America and Europe are most affected due to their dependence on imported electronics, while Asia-Pacific is experiencing cost pressures in device manufacturing. These tariffs are increasing development and deployment expenses. However, they are also encouraging local device assembly, regional software innovation, and a greater focus on scalable, software-centric therapeutic solutions.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $10.96 billion in 2025 to $14.11 billion in 2026 at a compound annual growth rate (CAGR) of 28.8%. The growth during the historic period can be attributed to increasing smartphone penetration in healthcare, growing acceptance of digital health solutions, expansion of telemedicine services, early regulatory approvals for digital therapeutics, and the rising burden of chronic diseases.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $38.19 billion in 2030 at a compound annual growth rate (CAGR) of 28.3%. The growth during the forecast period can be attributed to increasing reimbursement support for digital therapeutics, rising demand for personalized digital care, expansion of AI-driven treatment platforms, growing partnerships between healthcare providers and technology firms, and increasing emphasis on preventive digital health. Major trends in the forecast period include increasing adoption of software-based therapeutic solutions, greater integration of wearable health devices, growing use of remote patient monitoring platforms, expansion of evidence-based digital care programs, and enhanced focus on personalized treatment pathways.

The growing prevalence of chronic diseases is expected to support the growth of the digital therapeutics market going forward. Chronic diseases are long-term conditions that generally persist for one year or longer and require continuous medical care or restrict daily activities, or both. Digital therapeutics are software-based interventions that provide evidence-based therapeutic treatments to patients, supporting chronic disease management and expanding available treatment options. For instance, in March 2025, according to the Office for Health Improvement & Disparities (OHID), a UK-based unit of the Department of Health and Social Care, the GP-recorded prevalence of type 2 diabetes among adults aged 17 and over in England was 7.0% in March 2024, up from 6.8% in March 2023. Therefore, the growing prevalence of chronic diseases is driving the growth of the digital therapeutics market.

Major companies operating in the digital therapeutics market are concentrating on technological advancements such as prescription-only digital behavioral therapy platforms to increase treatment accessibility, strengthen patient engagement, and deliver clinically validated outcomes. A prescription-only digital behavioral therapy platform uses software-based interventions delivered through smartphones or tablets, incorporating evidence-based modules such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking. These platforms enable scalable, drug-free disease management while providing personalized patient support. For instance, in July 2023, Better Therapeutics, a US-based prescription digital therapeutics company, launched AspyreRx (formerly BT-001), a digital therapeutic designed for type 2 diabetes. The product provides a 90-day self-paced program through a smartphone application, incorporating weekly CBT lessons, personalized goal-setting, and tracking of blood glucose and lifestyle data; clinical trials showed sustained reductions in HbA1c, improvements in weight, and enhanced quality-of-life outcomes.

In July 2023, Big Health, a US-based provider of digital therapeutics, acquired Limbix for an undisclosed amount. The acquisition is expected to expand Big Health's existing product portfolio, which includes Sleepio for insomnia and Daylight for anxiety, by adding Limbix's SparkRx and another teenage medication in development for anxiety. Limbix is a US-based provider of digital therapeutics.

Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Software; Devices
• 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
• 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
• Subsegments:
• 1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software
• 2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
• Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Xealth; CogniFit Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Digital Therapeutics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Digital Therapeutics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Digital Therapeutics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Digital Therapeutics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Software-Based Therapeutic Solutions
  • 4.2.2 Rising Integration Of Wearable Health Devices
  • 4.2.3 Growing Use Of Remote Patient Monitoring Platforms
  • 4.2.4 Expansion Of Evidence-Based Digital Care Programs
  • 4.2.5 Enhanced Focus On Personalized Treatment Pathways

5. Digital Therapeutics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Healthcare Providers
• 5.3 Digital Health Companies
• 5.4 Patients
• 5.5 Insurance Providers

6. Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Digital Therapeutics PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Digital Therapeutics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Digital Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Digital Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Digital Therapeutics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Digital Therapeutics Market Segmentation

• 9.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Devices
• 9.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Business-To-Business (B2B), Business-To-Consumers (B2C)
• 9.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preventive Applications, Treatment Or Care-Related Applications
• 9.4. Global Digital Therapeutics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mobile Applications, Web-Based Platforms, Digital Therapeutics Software
• 9.5. Global Digital Therapeutics Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Wearable Devices, Biosensors, Digital Therapeutic Devices

10. Digital Therapeutics Market Regional And Country Analysis

• 10.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Digital Therapeutics Market

• 11.1. Asia-Pacific Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Digital Therapeutics Market

• 12.1. China Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Digital Therapeutics Market

• 13.1. India Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Digital Therapeutics Market

• 14.1. Japan Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Digital Therapeutics Market

• 15.1. Australia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Digital Therapeutics Market

• 16.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Digital Therapeutics Market

• 17.1. South Korea Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Digital Therapeutics Market

• 18.1. Taiwan Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Digital Therapeutics Market

• 19.1. South East Asia Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Digital Therapeutics Market

• 20.1. Western Europe Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Digital Therapeutics Market

• 21.1. UK Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Digital Therapeutics Market

• 22.1. Germany Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Digital Therapeutics Market

• 23.1. France Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Digital Therapeutics Market

• 24.1. Italy Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Digital Therapeutics Market

• 25.1. Spain Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Digital Therapeutics Market

• 26.1. Eastern Europe Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Digital Therapeutics Market

• 27.1. Russia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Digital Therapeutics Market

• 28.1. North America Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Digital Therapeutics Market

• 29.1. USA Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Digital Therapeutics Market

• 30.1. Canada Digital Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Digital Therapeutics Market

• 31.1. South America Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Digital Therapeutics Market

• 32.1. Brazil Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Digital Therapeutics Market

• 33.1. Middle East Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Digital Therapeutics Market

• 34.1. Africa Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Digital Therapeutics Market Regulatory and Investment Landscape

36. Digital Therapeutics Market Competitive Landscape And Company Profiles

• 36.1. Digital Therapeutics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Digital Therapeutics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Digital Therapeutics Market Company Profiles
  • 36.3.1. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Propeller Health Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. Digital Therapeutics Market Other Major And Innovative Companies

• Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health

38. Global Digital Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Digital Therapeutics Market

40. Digital Therapeutics Market High Potential Countries, Segments and Strategies

• 40.1 Digital Therapeutics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Digital Therapeutics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Digital Therapeutics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer